https://research.ouhsc.edu/news Parent Page: News id: 26727 Active Page: details id: 26917

News

OUHSC Research News – Monday, July 18, 2022


Published: Monday, July 18, 2022

OUHSC Research News – Monday, July 18, 2022

 

Notices and Reminders

 

SoonerTrack II Go-Live Announcement

The Office of Research Administration (ORA) is pleased to announce that the SoonerTrack II system is now live! This new system has replaced the SoonerTrack I system used to route grant applications and agreements. The launch webpage for the system is https://fs.ou.edu. User guides and training materials are available at https://research.ouhsc.edu/research-administration/soonertrack-ii-support   

If you have any questions, please contact soonertrackhelpdesk@ouhsc.edu.

**Please be aware that beginning July 11, all SoonerTrack tickets in Pre-Submission status (tickets that have not yet reached ORA) MUST be resubmitted through the new SoonerTrack.

 

Important SoonerTrack Update

Please note that to be added to routing forms as Principal Investigator (PI) or personnel, you must log into https://fs.ou.edu as soon as possible. Other than logging in and out, you do not need to do anything else at this time. However, if you do not perform this initial login step, your department support will not be able to route forms for you nor will other researchers be able to add you to their projects in SoonerTrack.  If you are routing a proposal/agreement in SoonerTrack II and can’t find your department, please contact your business administrator. If you have any questions, please contact us at soonertrackhelpdesk@ouhsc.edu.

 

SoonerTrack II Training Opportunities

Pre-scheduled SoonerTrack II training sessions are available at the following dates and times. All sessions are the same, so register for the one that best fits your schedule. Additional dates will be provided as needed (These sessions will be conducted via Zoom).  

  • Wednesday, July 20, 2022, 1:30 PM - 2:30 PM - Register here
  • Thursday, July 28, 2022, 10:00 AM – 11:00 AM- Register here

 

The Office of Vice President for Research (OVPR) and the Office of Research Administration (ORA) at the OU Health Sciences Center Announcing the Launch of the Newly Redesigned Website

We are excited to announce the launch of our newly redesigned website. The new design allows for streamlined menus and clear navigation, and offers quick and easy access to essential information for our faculty and staff. Explore the website at https://research.ouhsc.edu. We welcome your feedback. Please send any questions or comments to oradmin@ouhsc.edu.

 

NIH Reminder: All NIH-funded clinical trials are expected to register and submit results information to Clinicaltrials.gov, as per the “NIH Policy on Dissemination of NIH-Funded Clinical Trial Information for competing applications and contract proposals. The requirements for registration and results reporting are:

  • Recipients must ensure that their NIH-funded clinical trials are registered at ClinicalTrials.gov for public posting no later than 21 days after enrollment of the 1st participant.
  • Results information must be submitted to ClinicalTrials.gov no later than one year after primary completion date (with limited exceptions).

If your RPPR has associated clinical trials that do not comply with these requirements, you may receive errors that prevent the RPPR from being submitted.

 

Workshops and Seminars

Webinar I: Understanding the New NIH Data Management and Sharing Policy 

Date: Thursday, August 11, 1/24/22, 12:30 - 2:30 PM (Central)

Description: The NIH Office of Science Policy (OSP) and the Office of Extramural Research (OER) invite you to join them for an engaging and interactive webinar focused on the new DMS policy which goes into effect on January 25, 2023. In this webinar, you will learn about DMS policy expectations, the applicability of the policy, how to prepare a Data Management and Sharing Plan, and considerations for sharing data responsibly. Don't miss this valuable opportunity to hear from policy experts and get your questions answered. Registration: https://vfairs.zoom.us/webinar/register/WN_CtZuYKxtTeioXptg43JDgg

 

Webinar II: Diving Deeper into the New NIH Data Management and Sharing Policy 

Date: Thursday, September 22, 2022 / 12:30 - 2:30 PM (Central)

Description: The NIH Office of Science Policy (OSP) and the Office of Extramural Research (OER) invite you to join them for an engaging and interactive webinar focused on the new DMS policy which goes into effect on January 25, 2023. In this second webinar of the series, we will expand upon the information presented in the first webinar and dive deeper into topics including privacy protections for data from human participants and justifiable limitations on sharing data. Don't miss this valuable opportunity to hear policy experts provide the latest information and to get your questions answered.

Registration: https://vfairs.zoom.us/webinar/register/WN_3y9GFMc2SsWpv2GhIzOGsg

 

Data Science Workshop: Edit live Jupyter notebooks from the comfort of your favorite text editor

Speaker: Blaine Mooers, PhD

Date: Thursday, July 21, noon to 1 PM, virtual

Abstract: Jupyter notebooks are computational notebooks that support interactive computing in web browsers. These notebooks are popular with Python programmers. However, you can use the notebooks with over 100 other programming languages, including R, Julia, and C. The notebooks support the interleaving between blocks of code text written in markdown, math equations rendered with MathJax, and embedded images. Jupyter notebooks hold the promise of supporting literate programming and thereby reproducible research. Some workers have assembled research papers and even books from Jupyter notebooks. However, the Jupyter platform lacks several essential features of modern text editors. I will present two software solutions developed by others that address parts of this problem: GhostText (https://ghosttext.fregante.com/) and Quarto (https://quarto.org/).

GhostText is a browser extension that supports sending the text in any browser textarea (those boxes in webpages where you can enter free-form text) to your favorite text editor (e.g., Vim, NeoVim, VSC, Emacs, Sublime Text, Atom). The live cell of a Jupyter or Colab notebook is also a textarea. You can insert your favorite snippets with your text editor, and the textarea updates instantly. I also use GhostText to edit LaTeX documents in Overleaf, the browser-based LaTeX editor. I use the latter to prepare research papers, grant applications, slideshows, and posters.

Quarto is a command line tool that supports scientific publishing. Quarto uses Jupyter and Pandoc to convert Jupyter Notebooks and other documents into HTML, PDF, and docx files. Quarto works with Jupyter Lab, Rstudio, Visual Studio Code, Vim, Emacs, and Sublime Text. Quarto streamlines what had been a convoluted process.

Zoom Link: https://zoom.us/j/93134764583?pwd=emNmS2ZndFQrUnR2STRhdDRSc2EvUT09

 

OUHSC Funding Opportunities

Presbyterian Health Foundation (PHF) Bridge Grant Program – Request For Applications

  • Cycle II PHF Bridge Grant Program Deadline: July 29, 2022

The primary objective of the PHF Bridge Grant Program is to provide funding to enhance OUHSC faculty competitiveness for extramural funding. OUHSC Principal Investigators are eligible if they meet the following criteria: 1) have submitted an extramural application within the past 18 months that was scored but not funded, 2) are requesting over $750,000 in total direct costs and over $200,000 in total facilities and administration (F&A) costs; and 3) received a review that ranks applications  and provides critiques. 

IMPORTANT UPDATE: This program can now provide funding for up to $100,000 for one year. SALARY and FRINGE BENEFITS may be requested for the Principal Investigator(s) up to $25,000 in total (salary + fringe benefits = $25,000) with the remaining portion, $75,000, used to support the project costs. Guidelines and Application Form are attached or can be found here.  If you have any questions, please email  VPR@ouhsc.edu

 

The Presbyterian Health Foundation and the Oklahoma Center for Therapeutic Sciences 2022 pilot award

The Presbyterian Health Foundation (PHF) and the Oklahoma Center for Therapeutic Sciences (CTS) are soliciting proposals for Investigator Seed Grant Awards in drug and probe discovery. The current RFA is focused on funding pilot projects that utilize the Drug and Target Discovery (DTD) High Throughput Screening (HTS) Facility and the Laboratory of Molecular Structure and Function (MSF). DTD can perform screens of its 7 chemical libraries (~100,000 compounds) using cell-based high-content imaging, as well as fluorescence, fluorescence polarization, TR-FRET, absorbance, and luminescence of cell-based assays or assays using purified components. DTD has cell culture facilities and a full suite of detection, robotic, and imaging equipment designed to facilitate work in microwell plates (96-or 384-well formats). The Facility will assist investigators in the design and development of screen assays that can use all currently available assay readouts and formats. Funding for pilot projects that utilize MSF will be focused on the use of its structure-guided software tools.

Documents for the pilot award announcement and a brochure describing the capabilities of CTS are attached.

If you have any questions, please contact Matthew Hart, Ph.D. at Matthew-J-Hart@ouhsc.edu

 

Office of Technology Commercialization presents the following opportunities for researchers to engage with industry (click here for more information, or email otc@ou.edu or gina-mcmillen@ouhsc.edu).  

  • Almirall, a global biopharmaceutical company focused on skin health, is seeking partnering opportunities is medical dermatology.  Of interest are target immune-inalfmmatory pathways with rationale for dermatological indications, non-melanoma skin cancer or rare dermatological indications.  Any therapeutic modality and all stages of development will be considered.  Out of scope:  drug delivery reformulations, natural products, aesthetic and cosmetic products.   Submission entails a 1-pg non-confidential summary of technology with optional supplemental information.  (deadline 08/05).
  • Mars Petcare is seeking fermentation technologies to transform raw materials and boost product flavor and attractiveness for cats and dogs.  Plant-based raw materials/substances and technologies with opportunity to up-cycle agricultural side stream and human food industry by products are of high interest.  Novel fermentation equipment/systems and bio-separation or purification technologies are also of interest provided they allow for fermentation or improve over existing processes.    Submission entails a 1-pg non-confidential summary of technology with optional supplemental information.  (deadline 08/12).
  • The sustainable materials division of Faurecia, a tier-one automotive supplier interested in developing low carbon footprint alternative skins/leather/textiles, is seeking sustainable leather substitutes to decrease emission factors of interior parts.  All kinds of subsitutes or feedstock are of interest. Submission entails a 1-pg non-confidential summary of technology with optional supplemental information.  (deadline 08/12).

 

 NIH Notices 

NOTE: When only one application is allowed per Institution according to the sponsor instructions, a one-page letter of intent summarizing the proposed project should be submitted to the Vice President for Research at least two months prior to the application deadline (unless otherwise noted).  The letters of intent will be reviewed and a single application will be chosen for submission from the University.

 

NIH Funding Opportunities

 

Other Funding Opportunities

The Melanoma Research Alliance (MRA) - Patient-Centric Clinical Trial Team Science Awards

Description: The Melanoma Research Alliance (MRA) is pleased to announce a Special Opportunity RFP for Team Science Awards focused on patient-centric clinical trials, jointly funded by The Rising Tide Foundation for Clinical Cancer Research (RTFCCR) and MRA. MRA and RTFCCR will jointly support two team awards (each up to $1.5 million) for clinical trials with the potential to provide significant impact to melanoma patients. These awards seek to support novel, interventional clinical trials with the goal of making a significant difference to melanoma patients in the short term. Patient engagement must be actively demonstrated throughout the full life cycle of the clinical trial, including planning and dissemination.

Informational webinars: Informational webinars will be offered on July 26 at 9 am ET & July 28 at 11 AM ET. Applicants are highly encouraged to attend

Letters of Intent Due: October 5, 2022

Invited Full Proposals Due: January 18, 2023

Link to Full Announcement: CureMelanoma.org/RFP

 

Susan G. Komen Career Catalyst Research (CCR) Grants - call for research proposals from early career investigators

Description: For more than a decade Susan G. Komen Career Catalyst Research (CCR) Grants have fostered promising breast cancer researchers who are in the early stages of their faculty careers, conducting research that has unlocked new knowledge about breast cancer and helped advance patient care.  Through this grant mechanism, we seek to support those who will emerge as the next generation of key leaders in the quest to end breast cancer.  Eligibility: Junior faculty members working at academic institutions in the United States who have not held any faculty appointment for more than a total of six years are invited to apply for our Career Catalyst Research Grants. 

Letters of Intent Deadline: Extended to August 1, 2022
Full Application Due: October 5, 2022

Link to Full Announcement: https://bit.ly/3xmfvcn

 

Oklahoma Center for Adult Stem Cell Research (OCASCR)

Description: The overall goal of OCASCR is to help adult stem cell and regenerative medicine research thrive in Oklahoma and to serve as a trusted resource for public information on these topics. Grants are accepted for research, equipment, and travel/education, and other areas.

 

Documents to download